凯赛生物获得发明专利授权:“重组核酸序列、重组表达载体以及基因工程菌”

证券之星企业动态
Jul 12

证券之星消息,根据天眼查APP数据显示凯赛生物(688065)新获得一项发明专利授权,专利名为“重组核酸序列、重组表达载体以及基因工程菌”,专利申请号为CN202111155453.8,授权日为2025年7月11日。专利摘要:本发明公开了重组核酸序列、重组表达载体以及基因工程菌。其中,所述重组核酸序列包括串联启动子、赖氨酸脱羧酶基因以及增强细胞耐受压力的基因,所述串联启动子包括piclR启动子和...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10